Understanding and Treating Blood Cancers and Bone Marrow Transplants
Official title: Hematologic Malignancies and Bone Marrow Transplantation
Funded at Johns Hopkins University · NIH-11086178 · Data updated 2026-11-12
This program helps us learn more about blood cancers and related conditions, and find better ways to treat them, especially through bone marrow transplants.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project start | May 7, 1997 |
| Project end | May 31, 2027 |
| Funding year | 2025 |
| Award (this year) | $299,086 |
| NIH project number | 5P30CA006973-62 |
| Project ID | NIH-11086178 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients with hematologic malignancies (blood cancers) and those considering or undergoing bone marrow transplantation are the focus of this program's research.
✕Less likely to help
Patients without blood cancers or conditions related to bone marrow transplantation would not directly benefit from this specific research program.
What this research studies
The Sidney Kimmel Comprehensive Cancer Center is working to improve care for people with blood cancers and related conditions. This program brings together laboratory discoveries and patient care to find new treatments. Researchers are looking at changes in genes and cells that cause blood cancers, studying how blood cells develop normally and abnormally, and working to make bone marrow transplants safer and more effective. Their work moves from basic science in the lab to clinical trials with patients, and then uses patient observations to guide further lab research.
Why it matters
Potential benefit: If successful, this program could lead to more effective and safer treatments for various blood cancers and improve outcomes for patients undergoing bone marrow transplantation.
How similar studies have gone: This is a comprehensive program at an established cancer center, building upon existing knowledge and clinical experience in hematologic malignancies and bone marrow transplantation.
Where this research is happening
-
Johns Hopkins University
Baltimore, United States Active
Researchers
- Principal investigator: Jones, Richard J — Johns Hopkins University
- Study coordinator: Jones, Richard J
Related research
Other NIH-funded projects on the same topics.
-
Adapting flow cytometry to detect childhood leukemias in Kenya using a single-test screen
A low-cost, blood-based flow cytometry screen in Kenya aims to detect and triage suspected leukemias in children and young adults.
-
Understanding why patients with blood cancers start and stick with oral cancer medicines
A study to learn what helps or hinders Black patients with blood cancers in starting and continuing their prescribed oral cancer medicines.
-
Why some blood cancer cells survive after treatment by resisting natural killer cells
This work is trying to understand why leftover blood cancer cells in leukemia and multiple myeloma survive treatment by escaping natural killer immune cells.
-
Expanding blood cancer care and research to Brooklyn and Queens
Aimed at bringing more blood cancer care and clinical trials to Brooklyn and Queens to help a diverse patient community.
-
Adapting flow cytometry to detect blood cancers in Kenyan children and young people
A nationwide Kenyan effort will test a cheaper, single-blood-sample screening method using flow cytometry to screen for leukemia in kids and young adults who may have the disease.
-
Next-gen genetic engineering of CD45 to boost CAR-T therapy for blood cancers
A research team is developing a way to make CAR-T cells work for many blood cancers by re-engineering a common blood cell protein called CD45.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.